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Aims Nebulette is a 109 kDa modular protein localized in the sarcomeric Z-line of the heart. In vitro studies have suggested
a role of nebulette in stabilizing the thin filament, and missense mutations in the nebulette gene were recently shown to
be causative for dilated cardiomyopathy and endocardial fibroelastosis in human and mice. However, the role of
nebulette in vivo has remained elusive. To provide insights into the function of nebulette in vivo, we generated and studied
nebulette-deficient (nebl2/2) mice.
Methods
and results
Nebl2/2 mice were generated by replacement of exon 1 by Cre under the control of the endogenous nebulette pro-
moter, allowing for lineage analysis using the ROSA26 Cre reporter strain. This revealed specific expression of nebul-
ette in the heart, consistent with in situ hybridization results. Nebl2/2 mice exhibited normal cardiac function both
under basal conditions and in response to transaortic constriction as assessed by echocardiography and haemodynamic
analyses. Furthermore, histological, IF, and western blot analysis showed no cardiac abnormalities in nebl2/2mice up to
8 months of age. In contrast, transmission electron microscopy showed Z-line widening starting from 5 months of age,
suggesting that nebulette is important for the integrity of the Z-line. Furthermore, up-regulation of cardiac stress
responsive genes suggests the presence of chronic cardiac stress in nebl2/2 mice.
Conclusion Nebulette is dispensable for normal cardiac function, although Z-line widening and up-regulation of cardiac stress
markers were found in nebl2/2 heart. These results suggest that the nebulette disease causing mutations have dominant
gain-of-function effects.
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1. Introduction
Nebulette is a 109 kDa cardiac-specific sarcomeric protein, highly
homologous to the C-terminal Z-disc region of the larger protein
nebulin (500–900 kDa), which is predominantly expressed in skel-
etal muscle.1 Like nebulin, nebulette is composed of 35-residue
nebulin-like repeats, a serine-rich region, and a C-terminal SH3
domain.2 However, whereas nebulin contains up to 185 nebulin-like re-
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peats and extends from the Z-line along the length of the thin filament,
nebulette contains only up to 23 repeats and is localized at the Z-line
from which it protrudes only a short distance along the thin filament.2
The nebulin-like repeats of both nebulin and nebulette bind to the thin
filament components actin,3 – 6 tropomyosin 1,4,5,7 – 10 and troponin
T,5,9 while their C-terminal SH3 domains have been reported to inter-
act with myopalladin,11 palladin,11 a-actinin,4 zyxin,12 N-WASP,13 and
titin’s Zis1 and PEVK regions14–16 in the Z-disc. Additionally, nebulette
binds to filamin C8 and possibly Cypher/ZASP,8 whereas nebulin
C-terminal repeats M160–164 were reported to interact with
CapZ17 and desmin.18,19 It remains to be determined whether nebul-
ette can also interact with CapZ and desmin. Based on its interaction
with thin filament components and close connection to the actin fila-
ment along its length, nebulin was long thought to be a ruler regulating
thin filament length.1,20 However, recent findings by us and others have
revealed that it does not directly regulate thin filament length, but ra-
ther stabilizes the thin filament, allowing it reach its final length.17,21–23
Although nebulette is localized in the Z-line and does not extend the
length of the thin filament, loss of endogenous nebulette in chicken em-
bryonic cardiomyocytes as a result of overexpression of the nebulette
serine-rich region and/or SH3 domain resulted in shorter thin fila-
ments,24 similar to observations in skeletal muscle of nebulin knockout
(KO) mice.16,21 Thus, despite of its localization in the Z-line, also neb-
ulette appears to play a role in stabilizing the thin filament. Further-
more, consistent with the finding that nebulette repeats increase the
affinity of the tropomyosin–troponin T complex for F-actin,5 loss of
nebulette was reported to cause a reduction in tropomyosin and
troponin T staining along the thin filament without affecting the organ-
ization of the Z-line or the thick filament.7,24 The role of nebulette in
the Z-line remains elusive, but based on its high homology with the
C-terminal Z-line region of nebulin, the two proteins are thought to
play similar roles in the Z-line. Nebulin KO mice exhibit widened and
misaligned Z-lines,16,21,25 suggesting a role of nebulin in the mainten-
ance of Z-line width and the lateral registration of Z-lines, likely through
its binding to desmin.21,25 Furthermore, we recently showed that mice
deficient for the nebulin SH3 domain are more susceptible to eccentric
contraction-induced injury,26 consistent with a role of nebulin in main-
taining Z-line structure during load, protecting the muscle from injury.
The recent identification of nebulette variants in patients with dilated
cardiomyopathy (DCM) and endocardial fibroelastosis27 suggests
that nebulette may play a similar important role in the heart. The iden-
tified variants include four heterozygous missense mutations localized
within different regions of the nebulette gene, associated with DCM of
different severity and age of disease onset. The K60N, Q128R, and
G202R variants reside in the nebulin-like repeat region in the I-band
region, whereas the A592E variant is localized in the Z-line region.
The patients carrying the Q128R and A592 variants (the patient carry-
ing the A582 variant also carried a mutation in a-actinin 2) were
affected from birth, whereas the patients carrying the K60N and
G202R variants developed adult-onset DCM. The cardiomyopathy
phenotype was recapitulated in transgenic mouse models overexpres-
sing nebulette mutations, resulting in various phenotypes ranging from
embryonic lethality (K60N and Q128R) to adult-onset progressive
DCM (G202R and A592E) associated with disruption of I-band and
Z-line proteins.27,28 To provide new insights into the function of
nebulette in the heart in vivo, we generated and studied nebulette-
deficient (nebl2/2) mice. Surprisingly, nebl2/2 mice exhibited normal
cardiac function, although Z-line widening and up-regulation of markers
associated with cardiac stress were observed.
2. Methods
2.1 Generation of nebulette KO mice
Nebulette genomic DNA was isolated from a 129SVJ mouse genomic
library (Stratagene, La Jolla, CA, USA) and used to generate a nebulette-
targeting construct for the replacement of nebulette exon 1 by a
cre-FRT-neo-FRT cassette under the control of the endogenous nebulette
promoter essentially as described previously (Figure 1A).21 The targeting
construct was verified by sequencing and linearized with NotI before elec-
troporation into R1 embryonic stem cells at the Transgenic Core Facility at
the University of California, San Diego. G418-resistant ES clones were
screened for homologous recombination by BamHI digestion of ES cell
DNA and Southern blot analysis with the probe shown in Figure 1B.
G418-resistant ES clones were screened for homologous recombination
by Southern blot analysis with the probe shown in Figure 1B. The wild-type
(WT) allele is represented by the band of 8.5 kb, whereas the 5.4 kb band
represents the correctly targeted mutant allele. Cells from two independ-
ent homologous recombinant ES clones were microinjected into C57BL/6
Figure 1 Targeting of the nebulette gene. (A) Targeting strategy for generation of nebulette KO (nebl2/2) mice. A restriction map of the relevant gen-
omic region of nebulette is shown on top and the mutated locus after recombination is shown at the bottom. The black box indicates exon 1 and arrows
indicate frt sites. Neo, neomycin-resistance gene. (B) Detection ofWT and targeted alleles by Southern blot analysis after digestion with BamHI using the
probe shown in A. (C) Detection of nebulette protein by western blot analysis. a-Tubulin antibody was used as a loading control.
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blastocysts and transferred into pseudopregnant mice. Male chimeras result-
ing from the microinjections were bred with female Black Swiss mice to
generate germline-transmitted heterozygous nebulette KO mice (nebl+/2),
which were subsequently intercrossed to generate homozygous KO
mice (nebl2 /2). Offspring from intercrosses were genotyped by PCR
analysis using mouse tail DNA and WT (sense: GTGCCCCAGA
GACTTGGTAG; reverse: AGAGGGAGGGAGAAGGTCTG), and mu-
tant allele-specific primers (sense: GTTCGCAAGAACCTGATGCACA;
reverse: CTAGAGCCTGTTTTGCACGTTC). Successful ablation of the
nebulette gene was confirmed by western blot analysis using polyclonal
antibodies against nebulette (kindly provided by Dr Siegfried Labeit, Med-
ical Faculty Mannheim, University of Heidelberg, Germany). All animal stud-
ies were approved by the University of California San Diego Animal Care
and Use Committee and the Italian Ministry of Health. Animal procedures
were performed in full compliance with the guidelines for the Guide for the
Care and Use of Laboratory Animals, eighth edition (2011), published by
the US National Institutes of Health (NIH) and the Directive 2010/63/EU
of the European Parliament on the protection of animals use for scientific
purposes. Mice for experiments were sacrificed by cervical dislocation fol-
lowing anaesthesia by an intraperitoneal injection of a mixture of ketamine
(100 mg/kg) and xylazine (5 mg/kg).
2.2 b-Galactosidase staining
To perform fate mapping of nebulette-expressing cells, nebl+/2 mice were
crossed with the ROSA26 reporter line to generate double heterozygous
nebl+/2/R26Rmice in which lacZ is expressed from the ROSA26 promoter
after Cre-mediated recombination.29 E9.5 and E11.5 nebl+/2/R26R em-
bryos were fixed in 4% paraformaldehyde (PFA), and b-galactosidase stain-
ing of whole mount and transverse sections was performed as previously
described.21 Imaging was performed on a dissecting microscope (SV-6;
Carl Zeiss MicroImaging, Inc.) with a 35-mm camera (C-mount; Nikon).
2.3 In situ hybridization
Whole-mount in situ hybridization of paraffin sections at different stages of
mouse development was carried out using digoxigenin-labelled RNA
probes as previously described.30,31 A 718 bp RNA probe spanning bp
646–1363 of mouse nebulette XM_006497555 was utilized.
2.4 Histology, immunohistochemistry,
and transmission electron microscopy
For histology and immunostaining, mouse hearts were harvested and re-
laxed in 50 mM KCl in PBS before overnight fixation in 4% PFA in PBS.
For histology, hearts were dehydrated and embedded in paraffin, where-
after 10 mm sections were cut and analysed by staining with haematoxylin
and eosin, or Picrosirius red. For immunostainings, fixed hearts were satu-
rated in 10 and 30% sucrose in PBS and subsequently frozen in OCT,
whereafter 10 mm cryosections were cut. Permeabilization and blocking
were performed for 1 h in blocking solution containing 3% normal goat ser-
um, 0.3% Triton X-100, 50 mM glycine, and 1% cold water fish gelatin
(Sigma-Aldrich) in PBS after which sections were incubated with primary
antibodies in wash buffer (blocking buffer diluted 10 times in PBS) overnight
at 48C. The following primary antibodies were used: nebulette (1 : 50;
kindly provided by Dr Siegfried Labeit), myopalladin26 (1 : 50), palladin
621 (1 : 100; kindly provided by Dr Carol Otey, University of North Caro-
lina, Chapel Hill, NC, USA), N-WASP (1 : 25; Santa Cruz D15, #sc-10122),
cypher [1 : 100;32 CapZ b1 (5 mg/mL; Developmental Studies Hybridoma
Bank, University of Iowa, Iowa, IA, USA (DSHB), #1E5.25.4], sarcomeric
a-actinin (1 : 500; Sigma-Aldrich #A7811), desmin (1 : 80; Abcam
#ab8592), filamin C (1 : 1000; kindly provided by Dr Dieter Fu¨rst, Univer-
sity of Bonn, Germany), tropomyosin CH1 (5 mg/mL; DSHB, CH1), tropo-
nin T (5 mg/mL; DSHB, CT3), and tropomodulin (1 : 500; kindly provided by
Dr Mark Sussman, San Diego State University, San Diego, CA, USA). After
washing, sections were incubated at room temperature for 4 h with
rhodamine-labelled phalloidin (1 : 100, Sigma-Aldrich) or Alexa-Fluor-488
or -568-conjugated IgG secondary antibodies (1 : 500, Life Technologies).
Confocal microscopy was performed using an Olympus Fluoview FV1000
laser scanning confocal microscope with a ×60 oil immersion lens (N.A.
1.3; Olympus). Individual images (1024 × 1024) were converted to tiff for-
mat and merged as pseudocolour RGB images using ImageJ. For transmis-
sion electron microscopy (TEM), the heart was excised and fixed in 2% PFA
and 2% glutaraldehyde in 0.15 M sodium cacodylate buffer, pH 7.4, as pre-
viously described.33 Briefly, the left ventricle was cut into small pieces
(1 mm cubes) and stained overnight in 1% osmium tetroxide and 0.8%
potassium ferrocyanide. The following day, tissue was stained for 2 h in
2% uranyl acetate and subsequently dehydrated in a series of ethanol and
acetonewashes. The tissue was embedded in Durcupan resin (EMD, Gibbs-
town, NJ, USA) and ultrathin sections (60–70 nm) were stained with lead
citrate. Electron micrographs were recorded by using a JEOL 1200EX elec-
tron microscope operated at 80 kV. Z-line width was measured using the
ImageJ 2.0.0 software based on the analysis of .100 Z-lines per heart
from 2 to 3 mice per genotype and time point. Z-line values were binned
in 10 nm binds and plotted in histograms fitted with the Gaussian distribu-
tion using the PRISM 6 software.
2.5 Western blot analysis
Total left ventricular tissue was homogenized in lysis buffer (50 mM Tris
pH 7.5, 150 mM NaCl, 10 mM MgCl2, 0.5 mM DTT, 1 mM EDTA, 10% gly-
cerol, 2% SDS, 1% Triton X-100, Roche Complete Protease Inhibitor
Cocktail, 1 mM PMSF, 1 mM NaVO3, and 5 mM NaF) using a TissueLyser
II (Qiagen), whereafter western blot analysis was performed using primary
antibodies against the following proteins: nebulette (1 : 200), myopalladin
(1 : 1000), palladin 621 (1 : 500), N-WASP (1 : 50), CapZ b1 (0.4 mg/mL),
zyxin (1 : 50, Transduction laboratory no. Z45420), a-actinin (1 : 300
000), desmin (1 : 30 000), cypher (1 : 500), filamin C (1 : 10 000), tropomy-
osin (1 : 10 000), troponin I (0.2 ng/mL; DSHB TI-4), troponin T (2.3 ng/
mL), tropomodulin (1 : 1000), CARP (1 : 50), MYL2/MLC2v34 (1 : 5000),
MYL7/MLC2a34 (1 : 10 000), and myomesin (1 mg/mL; DSHB mMaC
myomesin B4). a-Tubulin antibodies (1 : 4000; Abcam) were used for
normalization.
2.6 In vivo cardiac physiology
For transthoracic echocardiography, mice were anaesthetized with 1% iso-
flurane and imaged as previously described.35 For surgical procedures,
mice were anaesthetized by an intraperitoneal injection of a mixture of ke-
tamine (100 mg/kg) and xylazine (5 mg/kg), and the depth of anaesthesia
was monitored by toe pinch. Cardiac haemodynamic parameters were
evaluated by insertion of a 1.4-Fr Millar catheter-tip micromanometer
catheter through the right carotid artery into the left ventricle. Pressure
was recorded at baseline and following stimulation with graded doses of
the b-adrenergic agonist dobutamine (0.75, 2, and 4 mg/kg/min) as previ-
ously described.36 Transaortic constriction (TAC) was performed with a
27-gauge needle as previously described.35 Echocardiography was per-
formed 14 days after TAC, and the pressure gradient was measured by
Doppler echocardiography. Only mice showing an adequate pressure gra-
dient (.70 mmHg) were included in the analysis. SHAM-operated mice
were used as controls.
2.7 RNA analyses
Total RNAwas isolated from left ventricles of mice 3 weeks after SHAM or
TAC surgery using TRIzol reagent (Life Technologies) according to the
manufacturer’s instructions. For quantitative RT-PCR (qRT-PCR), first-
strand cDNA synthesis was performed using the High-Capacity cDNA Re-
verse Transcription kit from Applied Biosystems (Life Technologies),
whereafter qRT-PCRwas performed in triplicate with custom-designed oli-
gos (see Supplementary material online, Table S1) using the SYBR Select
Master Mix (Life Technologies). Relative expression analysis was performed
using the DDCt method.
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2.8 Mechanical experiments in isolated
myofibrils
Mechanical experiments were performed at 158C in single myofibrils and
small bundles of a few myofibrils from frozen ventricular strips of nebl2/2
and WT mice as previously described.37 Myofibrils (30–80 mm long,
1–4 mm wide, initial sarcomere length around 2.2 mm) were mounted
between a length control motor and an opto-electronic force transducer,
and were maximally Ca2+-activated (pCa 4.5) and fully relaxed (pCa 8.0)
by fast (,5 ms) solution switching. Activating and relaxing solutions were
as previously described (EGTA 10 mM, MgATP 5 mM, free Mg2+ 1 mM,
and inorganic Pi ,5 mM).37 Maximal tension and the kinetics of force activa-
tion following rapid Ca2+ activation, force redevelopment following
release-restretch protocols, and force relaxation following rapid Ca2+
removal were measured (see Supplementary material online, Figure S3).
Quasi-steady-state sarcomere length–resting tension relations were deter-
mined in relaxing solution (pCa 8.0) for both myofibril groups. Ramp elonga-
tions of different extents (10–40% of the slackmyofibril length) were applied
to the preparations. Sarcomere length and resting tension were measured
several seconds after each length change, when most of stress relaxation
was over.
2.9 Statistical analysis
Data are presented as mean+ S.D. or S.E.M. as indicated. Statistical
comparisons betweenWT and nebl2/2mice were done using the unpaired
Student’s t-test. A value of P, 0.05 was considered significant.
3. Results
3.1 Generation of nebulette KO (nebl2/2)
mice
To study the role of nebulette in vivo, nebulette KO mice (nebl2 /2)
were generated by replacement of exon 1 by Cre under the control
of the endogenous nebl promoter (Figure 1A). Targeted ES cell clones
were identified by Southern blot analysis (Figure 1B), and the successful
ablation of nebulette was confirmed by PCR and western blot analysis
(Figure 1C). Unexpectedly, we also found a 23-fold down-regulation
inmRNA levels of lasp2 (encoding LIM and SH3 Protein-2/LIM-Nebulette),
Figure 2 Lineage tracing shows specific expression of nebulette in the heart. X-Galalactosidase staining of whole mount (left, right, and centre views)
and transverse sections of nebl+/2/R26R embryos at E9.5 and E11.5.
Figure 3 Western blot analysis on left ventricular lysate from WT
and nebl2/2 mice for various nebulette-associated and sarcomeric
proteins. a-Tubulin antibody was used as a loading control. The blots
are representative of at least three different experiments.
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Figure 4 TEM analysis show Z-disc widening and irregularities in the left ventricle from nebl2/2mice. (A) Representative electron micrographs of left ven-
tricle from 5- and 9-month-old WT and nebl2/2mice. Moderate Z-line widening was observed in nebl2/2mice and at 9 months of age, areas with severely
widened Z-discs were observed. Arrows show examples of wide Z-discs. Scale bar: 1 mm. (B) Analysis of Z-line widths (n ≥ 100 per heart, n ¼ 2–3 per
genotype, and time point). Histograms fitted with the Gaussian distribution are shown. The Gaussian fits of Z-line width in WT fibres are superimposed
on the histograms from the analysis of nebl2/2 fibres. The insert is a zoom-in of the Z-line measurements over 200 nm in 9-month-old nebl2/2 mice.
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a splice variant of nebulette transcribed from a distinct promoter38 (Fig-
ure 5 and see Supplementary material online, Table S2). While the nebl
gene consists of 28 exons, lasp2 is composed of only 7 exons, and en-
codes a protein with a domain structure significantly different from that
of nebl, i.e. LASP2 contains a LIM domain, three central nebulin repeats,
and an SH3 domain. Lasp2 exons 5, 6, and 7 correspond to nebl exons
24, 27, and 28, whereas lasp2 exons 1–4 are 5′ of nebl exon 1. It is pos-
sible that the replacement of nebl exon 1 and part of intron 1 with Cre
cDNA may have affected lasp2 splicing, leading to the dramatically de-
creased transcript levels of lasp2. Nebl2/2 mice were born at Mendel-
ian ratios, were indistinguishable from their WT littermates, and had a
normal life span.
3.2 Lineage analysis shows specific
expression of nebulette in the heart
The insertion of Cre under the control of the endogenous nebulette
promoter allowed us to perform lineage tracing by crossing hetero-
zygous nebulette KO (nebl+/2) mice with the ROSA26 Cre reporter
strain,29 which upon Cre-mediated recombination of the R26R locus
expresses lacZ, thus resulting in selective lacZ expression in
nebulette-expressing cells or precursors. E9.5 and E11.5 nebl+/2/
R26R mouse embryos were stained for b-galactosidase activity,
which revealed specific and homogeneous expression of nebulette
in the heart in agreement with its reported localization (Figure 2).
Consistent with these findings, whole-mount in situ hybridization ana-
lysis of WT embryos at E8.5, E9.5, and E11.5 revealed specific expres-
sion of nebulette in the heart (see Supplementary material online,
Figure S1).
3.3 Nebl2/2 mouse hearts have normal
cytoskeletal organization, but show
progressive Z-line widening
Nebl2 /2 mice had normal heart weight-to-body weight ratios and
histological analyses by haematoxylin and eosin, and Picro sirius red
stainings showed no cardiac abnormalities up till 8 months of age
(see Supplementary material online, Figure S2A and data now shown).
In addition, immunostainings for nebulette-associated and sarcomeric
proteins showed normal cytoskeletal organization and no effects on
the localization of any of the tested proteins (see Supplementary
material online, Figure S2B). Likewise, western blot analyses on left ven-
tricular lysate showed no changes in protein levels of various sarco-
meric proteins, many of which associated with nebulette (Figure 3).
On the other hand, TEM analysis revealed progressive Z-line abnormal-
ities, including regions with severe Z-line widening and irregularities, in
the left ventricle of nebl2/2 mice compared with WT controls starting
from around 5 months of age (Figure 4A). As evident from the
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Table 2 Echocardiographic analysis of 8-week-old male nebl2/2 mice compared with WT mice before and 14 days after
mechanical pressure overload induced by TAC
Before TAC 14 days after TAC
WT (n5 6) nebl2/2 (n 5 7) WT (n 5 6) nebl2/2 (n 5 7)
Age (weeks) 13.3+0.0 13.3+0.0 15.3+0.0*** 15.3+0.0§§§
Body weight (g) 26.7+1.1 26.1+1.6 27.5+0.6 26.6+1.7
Heart rate (bpm) 517+19 497+23 461+29 506+12
LVIDd (mm) 3.16+0.08 3.10+0.17 3.07+0.07 3.08+0.03
LVIDs (mm) 1.63+0.11 1.69+0.36 1.99+0.04*** 2.00+0.03§
IVSd (mm) 0.86+0.05 0.86+0.06 1.08+0.03*** 1.09+0.02§§§
LVPWd (mm) 0.92+0.02 0.88+0.09 1.09+0.01*** 1.07+0.03§§§
LV %FS 48.3+3.7 49.1+12.8 35.3+1.2*** 34.8+1.4§§
LVMd (mg) 110.4+18.1 101.0+15.7 148.9+1.8 128.1+18.8
LVM/BW (mg/g) 4.14+0.65 3.88+0.57 5.32+0.07 4.83+0.70
HW/BW (mg/g) 6.01+0.19 6.12+0.59
Data comparison was carried out before and after TAC. See the Table 1 legend for details and description of abbreviations.
TAC, transverse aortic constriction.
***P, 0.001 for WT TAC vs. WT baseline.
§P, 0.05.
§§P, 0.01.
§§§P, 0.001 for nebl2/2 TAC vs. nebl2/2 baseline.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1 Echocardiographic analysis of 9-month-old male
nebl2/2 mice compared with WT mice under basal
conditions
WT (n5 6) nebl2/2 (n5 6)
Body weight (g) 35.5+2.6 33.2+2.6
Heart rate (bpm) 574+44 568+72
LVIDd (mm) 4.03+0.58 3.86+0.43
LVIDs (mm) 2.54+0.50 2.29+0.47
IVSd (mm) 0.64+0.05 0.61+0.03
LVPWd (mm) 0.63+0.05 0.62+0.04
LV %FS 37.3+3.5 41.1+6.2
LVM (mg) 87.7+17.2 77.9+15.2
LVM/BW (mg/g) 2.47+0.05 2.34+0.04
All data are presented as mean+ S.D.
BW, body weight; LVIDd, left ventricular internal diameter in diastole; LVIDs, left
ventricular internal diameter in systole; IVSd, interventricular septal thickness in
diastole; LVPWd, left ventricular posterior wall thickness in diastole; LV %FS, left
ventricular fractional shortening; LVM, left ventricular mass; bpm, beats per minute.
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histograms in Figure 4B, moderately increased Z-line width was ob-
served in the left ventricle of nebl2/2 mice both at 5 and 9 months
of age, while regions with severely widened Z-lines (.250 nm) were
observed at 9 months of age (5% of Z-lines). Furthermore, localized
areas with an irregular Z-line were observed as shown in Figure 4A (top
centre). The average Z-line width inWT and nebl2/2micewas 79+ 11
and 119+ 28 nm at 5 months of age and 85+14 and 122+ 67 nm at
9 months of age. No abnormalities in mitochondria or other organelles
were observed.
3.4 Nebl2/2 mice exhibit normal cardiac
morphology and function both under basal
conditions and in response to mechanical
pressure overload
To determine the effect of nebulette KO on cardiac morphology
and function, echocardiography was performed on 8-week- and
9-month-old nebl2/2mice comparedwithWT control mice. As shown
in Tables 1 and 2, no significant differences were found between nebl2/2
and WT mice in any of the parameters. Likewise, haemodynamic func-
tion, as assessed by cardiac catheterization of 12-week-old nebl2/2
mice and WT in the absence and presence of graded doses of
dobutamine, was comparable in nebl2/2 and WT mice (Table 3). To de-
termine the response to mechanical pressure overload, 8-week-old
nebl2/2 and WT mice were subjected to TAC. Pressure gradients
were measured by Doppler echocardiography, and cardiac morphology
and function was evaluated by echocardiography 2 weeks after the pro-
cedure. As shown in Table 2, nebl2/2 andWTmice showed a similar car-
diac hypertrophic response with a consequent reduction in fractional
shortening. Thus, we conclude that ablation of nebulette has no effect
on cardiac morphology and function, either at basal conditions or in re-
sponse to mechanical pressure overload for up to 2 weeks.
3.5 Modulation of markers of cardiac
remodelling in nebl2/2 mice
To determine the potential effect of nebulette KO on cardiac gene
expression under basal conditions and following mechanical stress,
we performed qRT-PCR on left ventricular tissue from nebl2/2 and
WT mice following TAC or SHAM surgery (Figure 5 and see Supple-
mentary material online, Table S2). This revealed up-regulation of
several markers of pathological cardiac remodelling in nebl2 /2 left
ventricle, including skeletal muscle alpha-actin (acta1), natriuretic peptide
A (nppa/ANF), natriuretic peptide B (nppb/BNP), beta-cardiac myosin hea-
vy chain (myh7), and cardiac ankyrin repeat protein/ankyrin repeat domain
1 (ankrd1). The highest levels of up-regulation were found under basal
conditions where in particular acta1 (22.5-fold), nppa (8.5-fold), and
nppb (3.9-fold) were highly up-regulated. In addition, nppa (2.7-fold),
acta1 (2.2-fold), and ankrd1 (1.9-fold) were up-regulated after TAC.
Collagen type III, alpha 1 (col3a1) was slightly up-regulated under basal
conditions (1.4-fold), while other markers of fibrosis, such as trans-
forming growth factor, beta 1 (tgfb1) and connective tissue growth factor
(ctgf), were unchanged. No changes in apoptosis-related genes [cas-
pase 3 (casp3), B-cell CLL/Lymphoma 2 (bcl2), bcl2-associated X-protein
(bax), and tumour protein p53 (tp53)] were found. To determine
whether the absence of a cardiac functional phenotype in nebl2/2
mice may be due to compensation by nebulin, we performed
qRT-PCR for nebulin (neb) and found a 3.4-fold up-regulation in
nebl2/2 mice subjected to SHAM, while no changes were found in
TAC-operated mice. On the other hand, western blot analysis on
left ventricular tissue lysate showed barely detectable levels of nebulin
in both WT and nebl2 /2 mice, and IF staining showed no specific
staining for nebulin in nebl2/2 hearts (data not shown). This is consist-
ent with the previously reported very low level of nebulin in the heart,
where it is expressed in only a small fraction of cardiomyocytes.21
Thus, the slight increase in nebulin transcript levels in nebl2/2 hearts
under basal conditions is unlikely to compensate for the absence of
nebulette.
3.6 Sarcomere mechanics and cross-bridge
kinetics are unaffected in nebl2/2 hearts
To determine whether the absence of nebulette may affect sarcomere
mechanics at rest and/or during contraction, we compared biomechan-
ical properties of myofibril preparations from 1-year-old nebl2/2 and
WTmice. As shown in Figure 6, no significant differences in mean sarco-
mere slack length and resting sarcomere length–tension relationships
were found in WT and nebl2/2 myofibrils. In WT myofibrils, Ca2+-
activated contraction and kinetic parameters were essentially the
same as those previously reported in mouse ventricular myofibrils37
(Table 4). Neither maximal active tension, nor the kinetics of force
generation and relaxation following rapid Ca2+ increase and removal,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 3 Cardiac haemodynamic properties of
12-week-old male nebl2/2 mice compared with WT mice
at baseline and following dobutamine stimulation
DOB WT (n 5 8) nebl2/2 (n 5 8)
Heart rate (bpm) Basal 392+44 408+13
0.75 u 422+33 430+35
2 u 468+35 462+32
4 u 522+47 510+16
LVPmax (mmHg) Basal 133+17 122+16
0.75 u 145+14 132+16
2 u 158+14 143+13
4 u 158+21 147+11
dP/dtmax (mmHg/s) Basal 10003+1166 11834+2576
0.75 u 11829+1532 13363+2599
2 u 16126+1858 16743+3087
4 u 20464+1796 20528+2145
dP/dtmin (mmHg/s) Basal 28164+1368 27997+1306
0.75 u 29559+1826 29105+1317
2 u 212017+2415 210925+1358**
4 u 214080+2671 213542+1314
EDP (mmHg) Basal 0.58+2.31 21.00+1.02
0.75 u 0.12+1.61 20.93+1.40
2 u 20.34+1.77 21.00+1.50
4 u 0.02+1.96 20.50+1.53
Exp. Tau (ms) Basal 10.7+1.26 11.5+2.2
0.75 u 9.6+1.0 10.7+1.5
2 u 7.9+0.7 9.3+1.2*
4 u 6.7+0.6 7.3+1.0
HW/BW (mg/g) 4.3+0.5 4.0+0.3
Values are mean+ S.D.
LVPmax, maximum end-systolic left ventricular pressure; dP/dtmax, maximum positive
first derivative of LVP (contractility); dP/dtmin, maximum negative first derivative of LVP
(relaxation); EDP, end-diastolic pressure; Exp. Tau, experimental Tau; DOB,
dobutamine; u, units.
*P, 0.05.
**P, 0.01.
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were significantly different in WT and nebl2/2 myofibrils. The results
demonstrate that cardiac sarcomere mechanics and cross-bridge
kinetics are not affected by the absence of nebulette.
4. Discussion
Although nebulette has been extensively studied in vitro and nebulette
gene mutations have been associated with DCM with or without asso-
ciated endocardial fibroelastosis,27 the functional role of nebulette in
the heart has remained elusive. Therefore, to provide insights into
the role of nebulette in vivo, we generated and studied nebl2/2 mice.
4.1 Nebl2/2 mice exhibit no cardiac
functional phenotype, but develop
progressive Z-line widening and
up-regulation of cardiac stress markers
Surprisingly, nebl2/2 mice exhibited no functional cardiac phenotype
or changes in myofilament function. Nebl2/2 mice had a normal life
span, even though ultrastructural analyses of the left ventricle revealed
moderate Z-line widening, including areas with severely increased
Z-line width, similar to observations in skeletal muscle of nebulin-
deficient mice.21 This suggests that nebulette, like nebulin,16,21,26 is im-
portant for the maintenance of Z-line structure and integrity in cardiac
muscle, although the Z-line abnormalities in nebl2/2mice were not suf-
ficient to affect cardiac function. Furthermore, the presence of cardiac
stress in nebl2/2mice is indicated by the increased expression of stress
responsive genes in the left ventricle of nebl2/2 mice both under basal
Figure 5 Up-regulation of transcript levels of nebulin and markers of cardiac pathological remodelling in nebl2/2 heart. qRT-PCR analysis for nebulin
and cardiac markers on left ventricular tissue from WT and nebl2/2 mice 3 weeks after SHAM or TAC surgery (n ¼ 3 mice per group performed in
triplicate). *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001.
Figure 6 Average sarcomere–length resting tension relationship in
myofibrils from WT and nebl2 /2 left ventricle. Each data point is
mean+ S.E.M. from 5 to 15 myofibrils. Logarithmic curves are fitted
to the data points.
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conditions (nppa, nppb, acta1, and myh7) and following TAC (nppa,
acta1, and ankrd1).
4.2 No changes in the expression and
location of sarcomeric proteins in nebl2/2
mouse hearts
Knockdown of nebulette in chicken embryonic cardiomyocytes has
previously been associated with decreased thin filament length and re-
duced tropomyosin and troponin T along the thin filament.7,24 In con-
trast, we found no changes in the expression levels and localization of
tropomyosin and troponin T or any other known nebulette interaction
partners in nebl2/2 hearts. In particular, although N-WASP has been
shown to be targeted to the Z-line through interaction with the SH3
domain of nebulin and nebulette in a GSK3b-dependent manner,13
its localization in the Z-line was unaffected by the absence of nebulette,
consistent with our recent findings in mice deficient for the nebulin
SH3 domain.26 The absent effect of nebulette KO on the expression
and localization of nebulette interaction partners is in contrast to ob-
servations in transgenic mice overexpressing different DCM-associated
nebulette mutations.27 In these studies, depending on the overex-
pressed mutation, various sarcomeric proteins were found to be
down-regulated (troponin T, troponin I, tropomyosin, ALP, Cypher/
ZASP, a-actinin 2, and myopalladin), cleaved (filamin C and myopalla-
din), smeared (myopalladin and a-actinin 2), or lost from the Z-line
(desmin).27 It is unclear whether these changes are direct conse-
quences of the mutations or indirect secondary changes as a conse-
quence of the resulting cardiomyopathy. Also, it is possible that the
non-physiological overexpression of mutant nebulette in transgenic
mice may cause non-specific effects and a better model system would
be to generate knockin mice for the mutations, ensuring expression at
physiological levels. Nevertheless, the absence of a cardiac functional
phenotype in nebl2/2mice, despite the fact that nebulettemissense mu-
tations have been found to result in severe DCM and endocardial fi-
broelastosis in both human and transgenic mouse models,27,28
suggests that the identified nebulette gene mutations have dominant
gain-of-function effects and could explain why no nebulette loss-of func-
tion mutations leading to the complete absence of nebulette have been
found in DCM patients. A similar example has been observed with the
myotilin KO mouse model,39 which exhibits no phenotype, although
myotilin gene mutations are causative for limb girdle muscular dys-
trophy 1A, myofibrillar myopathy, and spheroid body myopathy, and
transgenic mice overexpressing myotilin mutations develop a myop-
athy phenotype.40 Similarly, while ankrd1 gene mutations have been
described in patients with human dilated and hypertrophic cardiomy-
opathy,41 – 43 CARP/Ankrd1 KO mice exhibit no cardiac phenotype
either under basal conditions or following TAC.43 It should also be
pointed out that it is well known that differences in genetic background
can influence the phenotype.44 The nebl2/2 mice were generated and
analysed in a mixed sv129/Black Swiss background in our study. It is
possible that nebl2/2micemay display cardiac phenotypes in a different
genetic background.45
5. Conclusions
Although nebulette has been implicated in DCM, our results demon-
strate that nebl2 /2 mice exhibit normal cardiac function, suggesting
that nebulette is dispensable for normal cardiac function. This is in con-
trast to findings in nebulin KOmice, which recapitulate many of the fea-
tures of nemaline myopathy.21,46 Nevertheless, Z-line widening in
nebl2/2 hearts and the presence of localized areas with severe Z-line
widening suggest a role of nebulette for the maintenance of Z-line in-
tegrity, similar to nebulin in skeletal muscle.6,21,26 The absence of a
functional phenotype in nebl2/2 mice under basal conditions up to 9
months of age and following 2 weeks of TAC does not exclude that
the nebl2/2mice may display impaired cardiac function in old age, after
long-term TAC, or in response to other types of stress conditions, such
as cardiac ischaemia, in particular since the up-regulation of cardiac
stress responsive genes indicates the presence of chronic cardiac stress
in nebl2/2 mice. The fact that ablation of nebulette has no functional
consequence in our study suggests that nebulette missense mutations,
which are associated with DCM and endocardiac fibroelastosis, are
not loss-of-function mutations. Further studies are needed to deter-
mine the exact mechanisms linking nebulette missense mutations to
human cardiomyopathy.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
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Table 4 Tension generation and relaxation in ventricular myofibrils from 1-year-old nebl2/2 mice and WT mice at 158C
Myofibril batches Tension generation Relaxation
Slow phase Fast phase
P0 (mN mm
22) kACT (s
21) kTR (s
21) Duration (ms) kREL (s
21) kREL (s
21)
WT 82+12 (12) 8.9+0.4 (14) 8.6+0.5 (14) 65+6 (14) 1.79+0.20 (14) 25.3+3.1 (14)
nebl2/2 83+9 (14) 8.4+0.6 (14) 8.4+0.8 (14) 79+6 (14) 1.51+0.11 (15) 23.4+1.9 (13)
All values are presented as mean+ S.E.M. Numbers in parentheses are the number of myofibrils.
Full tension relaxation kinetics were characterized by the duration and rate constant of tension decay of the isometric slow relaxation phase (slow kREL) and the rate constant of the fast
relaxation phase (fast kREL; see Supplementary material online, Figure S3).
P0, maximum isometric tension; kACT, rate constant of tension rise following a step-wise pCa decrease (8.0 3.5) by fast solution switching; kTR, rate constant of tension redevelopment
following release-restretch of maximally activated myofibrils.
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